Melanie Senior

Melanie Senior is an experienced biopharma reporter and science writer with a focus on healthcare, pricing, and market access issues. Since January 2018, Melanie has worked as a biopharma reporter and science writer for Nature Portfolio while also serving as a specialist writer in life sciences for Evaluate Ltd., Nature, IN VIVO, and various biotech companies. Prior roles include biopharma writer and analyst at EY, senior analyst and writer at Real Endpoints, and bureau chief in Europe for Elsevier Business Intelligence. Melanie holds a Bachelor's degree in Natural Sciences from the University of Cambridge and multiple master's degrees in International Health Technology Assessment, Pricing and Reimbursement from The University of Sheffield and in Nutrition Sciences from St. Mary's University, Twickenham.